A recent study used zinc finger nucleases via RNA electroporation to knockout PD-1 in TILs on a clinical scale in order to treat metastatic melanoma [68], however, limited success meant only in vitro evaluation of the modified cells was possible. The gene discussed is PDCD1; the disease is metastatic melanoma.